Search

Maher Planinka Albitar

from Valley Center, CA
Age ~69
Get Report
Also known as:
Maher P Albitar, Maher P Albiter, Albitar Maher, Maher R
Phone and address:
27165 Kiavo Dr, Valley Center, CA 92082
(949) 842-4250
Related to:
Elizabeth Mahar, 40Jeffrey RentzJohn Rentz, 74Stephanie K Sinopoli, 65Peter J Mahar, 71
Connected to:
Guadalupe Albiter, 73Laura Albiter, 38Nadia M Albiter, 44Gary J Albitre, 66Jessica L Albitz, 41Lorie M Albitz, 71Adina A Albizo, 46Shaina E Albizu, 40Christopher D Albl, 64Ronald Alblas, 46

Maher Albitar Phones & Addresses

  • 27165 Kiavo Dr, Valley Center, CA 92082 (949) 842-4250
  • 35 Hawksmoor, Aliso Viejo, CA 92656
  • Laguna Hills, CA
  • 1515 Holcombe Blvd, Houston, TX 77030 (713) 794-1292
  • 3 River Rock Dr, Trabuco Canyon, CA 92679
  • Coto de Caza, CA
  • 3715 Elkins Rd, Sugar Land, TX 77479 (281) 265-6060
  • Bryn Mawr, PA
  • Philadelphia, PA
  • San Diego, CA
  • 8715 Sunny Ridge Dr, Houston, TX 77095

Work

Position: Medical Professional

Education

School / High School: University of Damascus / Faculty of Medicine

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Anatomic & Clinical Pathology, 1987

Specialities

Anatomic & Clinical Pathology

Professional Records

License Records

Maher Albitar

Address:
Valley Center, CA
Phone:
(949) 275-7564 (Work)
License #:
MD06481 - Active
Category:
Physician
Issued Date:
Oct 17, 1984
Expiration Date:
Jun 30, 2018
Type:
Allopathic Physician (MD)

Maher Albitar

Address:
Valley Center, CA
License #:
MD06481 - Active
Category:
Physician
Issued Date:
Oct 17, 1984
Expiration Date:
Jun 30, 2018
Type:
Allopathic Physician (MD)

Maher Albitar

License #:
MT016945T - Expired
Category:
Medicine
Type:
Graduate Medical Trainee

Maher Albitar

Address:
California
Houston, TX 77095
License #:
MD036474E - Active
Category:
Medicine
Type:
Medical Physician and Surgeon

Maher Albitar

Address:
12701 Commonwealth Dr SUITE 9, Fort Myers, FL
31 Columbia, Aliso Viejo, CA
Phone:
(239) 768-0600
License #:
131761 - Active
Category:
Health Care
Issued Date:
Mar 24, 2017
Effective Date:
Mar 24, 2017
Expiration Date:
Jan 31, 2019
Type:
Medical Doctor

Medicine Doctors

Maher Albitar Photo 1

Dr. Maher Albitar, San Juan Capistrano CA - MD (Doctor of Medicine)

View page
Specialties:
Anatomic & Clinical Pathology
Address:
33608 Ortega Hwy, San Juan Capistrano, CA 92675
(949) 728-4784 (Phone)
Certifications:
Anatomic & Clinical Pathology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Damascus / Faculty of Medicine
Medical School
Damascus Med Sch Hosp
Medical School
Rhode Island Hospital
Medical School
Hospital Of The University Of Pennsylvania
Medical School
University Of Pennsylvania
Maher Albitar Photo 2

Maher Albitar

View page
Specialties:
Clinical Pathology
Work:
NeoGenomics Laboratories
5 Jenner STE 100, Irvine, CA 92618
(239) 768-0600 (phone), (239) 690-4237 (fax)
Languages:
English
Description:
Dr. Albitar works in Irvine, CA and specializes in Clinical Pathology.
Maher Albitar Photo 3

Maher Albitar, San Juan Capistrano CA

View page
Specialties:
Internal Medicine
Hematology
Medical Genetics
Clinical Genetics
M.D.
Pathology
Anatomic Pathology & Clinical Pathology
Work:
Quest Diagnostics Nichols Institute
33608 Ortega Hwy, San Juan Capistrano, CA 92675
Education:
University Of Damascus (1979)
Maher Albitar Photo 4

Maher Albitar, San Juan Capistrano CA

View page
Specialties:
Pathologist
Address:
33608 Ortega Hwy, San Juan Capistrano, CA 92675
Education:
University of Damascus, Faculty of Medicine - Doctor of Medicine
Hospital of the University of Pennsylvania - Fellowship - Genetics
Hospital of the University of Pennsylvania - Fellowship - Hematology (Pathology)
Rhode Island Hospital - Residency - Pathology
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Maher Albitar
Managing
Alba Bioscience, LLC
Promote Use of Scientific Technologies F
31172 Doral Pl, Laguna Beach, CA 92677
Maher Albitar
Managing
Molecular Clinical Trials, LLC
Health Care Medical Doctors
31172 Doral Pl, Laguna Beach, CA 92677
Maher Albitar
Doctor Of Medicine
Albitar
Offices and Clinics of Medical Doctors
1515 Holcombe Blvd, Houston, TX 77030
(713) 794-1292

Publications

Us Patents

Using Plasma Proteomic Pattern For Diagnosis, Classification, Prediction Of Response To Therapy And Clinical Behavior, Stratification Of Therapy, And Monitoring Disease In Hematologic Malignancies

View page
US Patent:
7622306, Nov 24, 2009
Filed:
Apr 20, 2005
Appl. No.:
11/110374
Inventors:
Maher Albitar - Coto de Caza CA, US
Elihu H. Estey - Houston TX, US
Hagop M. Kantarjian - Bellaire TX, US
Francis J. Giles - Bellaire TX, US
Michael J. Keating - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
G01N 24/00
G01N 1/00
G01N 1/10
G01N 33/48
G01N 33/00
A61K 49/00
A01N 61/00
A61K 31/00
US Classification:
436173, 473174, 473179, 473 63, 473 64, 473 86, 424 91, 424 92, 514 1
Abstract:
The present invention demonstrates that the diagnosis and prediction of clinical behavior in patients with hematologic malignancies, such as leukemia, can be accomplished by analysis of proteins present in a plasma sample. Thus, in particular embodiments the present invention uses plasma to create a diagnostic or prognostic protein profile of a hematologic malignancy comprising collecting plasma samples from a population of patients with hematologic malignancies; generating protein spectra from the plasma samples with or without fractionation; comparing the protein spectra with clinical data; and identifying protein markers in the plasma samples that correlate with the clinical data. Protein markers identified by this approach can then be used to create a protein profile that can be used to diagnose the hematologic malignancy or determine the prognosis of the hematologic malignancy. Potentially these specific proteins can be identified and targeted in the therapy of these malignancies.

Myeloperoxidase Detection In Diagnosis And Prognosis Of Hematopoietic Disorders

View page
US Patent:
7670790, Mar 2, 2010
Filed:
Jul 16, 2009
Appl. No.:
12/504415
Inventors:
Maher Albitar - Coto De Caza CA, US
Assignee:
Quest Diagnostics Investments Incorporated - Wilmington DE
International Classification:
G01N 33/53
US Classification:
435 71, 435 791, 435 792
Abstract:
The present invention relates to the diagnosis of hematopoietic disorders and to determining the prognosis of patients affected by such disorders. The methods generally comprise determining a level of myeloperoxidase in a body fluid sample from the individual and using the level as a factor for diagnosing the disorder in the mammal or as a factor for determining the prognosis of a patient diagnosed with such a disorder. Myelodysplastic syndrome, acute myeloid leukemia and chronic myeloid leukemia are exemplary disorders. Also provided are method of cancer therapy involving reducing the level of myeloperoxidase in the body fluid of the individual.

Assay For Detecting Genetic Abnormalities In Genomic Nucleic Acids

View page
US Patent:
8093063, Jan 10, 2012
Filed:
Nov 29, 2007
Appl. No.:
11/947056
Inventors:
Maher Albitar - Coto De Caza CA, US
Assignee:
Quest Diagnostics Investments Incorporated - Wilmington DE
International Classification:
G01N 33/00
G01N 33/566
G01N 33/543
G01N 33/53
C12Q 1/68
C12M 3/00
C07H 21/04
US Classification:
436 94, 435 611, 435 71, 4352872, 436501, 436518, 536 231, 536 243
Abstract:
The present invention provides methods of detecting unamplifed genomic nucleic acid anchored to a solid support. The methods are useful for the detecting genetic abnormalities associated with various diseases, diagnosis, and prognosis.

Using Plasma Proteomic Pattern For Diagnosis, Classification, Prediction Of Response To Therapy And Clinical Behavior, Stratification Of Therapy, And Monitoring Disease In Hematologic Malignancies

View page
US Patent:
8097468, Jan 17, 2012
Filed:
Oct 21, 2009
Appl. No.:
12/582998
Inventors:
Maher Albitar - Coto de Caza CA, US
Elihu H. Estey - Houston TX, US
Hagop M. Kantarjian - Bellaire TX, US
Francis J. Giles - Bellaire TX, US
Michael J. Keating - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
G01N 24/00
G01N 1/00
G01N 1/10
G01N 33/00
G01N 33/48
A61K 49/00
A61K 31/00
A01N 61/00
US Classification:
436173, 436 63, 436 64, 436 86, 436174, 436179, 424 91, 424 92, 514 1
Abstract:
The present invention demonstrates that the diagnosis and prediction of clinical behavior in patients with hematologic malignancies, such as leukemia, can be accomplished by analysis of proteins present in a plasma sample. Thus, in particular embodiments the present invention uses plasma to create a diagnostic or prognostic protein profile of a hematologic malignancy comprising collecting plasma samples from a population of patients with hematologic malignancies; generating protein spectra from the plasma samples with or without fractionation; comparing the protein spectra with clinical data; and identifying protein markers in the plasma samples that correlate with the clinical data. Protein markers identified by this approach can then be used to create a protein profile that can be used to diagnose the hematologic malignancy or determine the prognosis of the hematologic malignancy. Potentially these specific proteins can be identified and targeted in the therapy of these malignancies.

Quantification Of Fusion Proteins And Their Activity From Chromosomal Translocation

View page
US Patent:
8124351, Feb 28, 2012
Filed:
Nov 14, 2006
Appl. No.:
12/094112
Inventors:
Maher Albitar - Coto de Caza CA, US
Hagop Kantarjian - Bellaire TX, US
Francis Giles - Bellaire TX, US
Iman Jilani - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
Quest Diagnostics Incorporated - San Clemente CA
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The present invention concerns the detection of gene products resulting from chromosomal translocations, including fusion proteins comprising a first and second region. In particular, the fusion proteins are identified following subjecting a sample comprising the proteins to a bead comprising an antibody to a first region, followed by subjecting the bead-antibody-fusion complex to a second antibody directed against the second region, thereby detecting the fusion protein. In particular aspects, the invention is employed to provide prognosis for an individual with cancer, to identify suitability for a particular cancer therapy, and/or to monitor response of a patient to a therapy, for example.

Methods For Detecting Tcr-Gamma Gene Rearrangement

View page
US Patent:
8367330, Feb 5, 2013
Filed:
Jun 24, 2009
Appl. No.:
12/491170
Inventors:
Maher Albitar - Coto De Caza CA, US
Assignee:
Quest Diagnostics Investments Incorporated - Wilmington DE
International Classification:
C12Q 1/68
US Classification:
435 61
Abstract:
The invention provides methods for detection of TCR-γ nucleic acid in acellular body fluid. The methods can be used to detect the TCR-γ gene rearrangement in acellular body fluid. The detection of TCR-γ gene rearrangement is useful in determination of clonality of T-cell population. The invention is useful in the diagnosis of lymphoproliferative disorder.

Methods For Detecting Gene Dysregulation By Intragenic Differential Expression

View page
US Patent:
8426133, Apr 23, 2013
Filed:
May 24, 2010
Appl. No.:
12/786266
Inventors:
Heather R. Sanders - Winchester CA, US
Maher Albitar - Coto De Caza CA, US
Aurelia Meloni-Ehrig - Gainesville VA, US
Assignee:
Quest Diagnostics Investments Incorporated - Wilmington DE
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435 612, 435 912
Abstract:
Described herein are methods, compositions and kits directed to the detection of gene dysregulations such as those arising from gene fusions and/or chromosomal abnormalities, e. g. translocations, insertions, inversions and deletions. Samples containing dysregulated gene(s) of interest may show independent expression patterns for the 5′ and 3′ regions of the gene. The methods, compositions and kits are useful for detecting mutations that cause the differential expression of a 5′ portion of a target gene relative to the 3′ region of the target gene.

Measuring Circulating Therapeutic Antibody, Antigen And Antigen/Antibody Complexes Using Elisa Assays

View page
US Patent:
8501423, Aug 6, 2013
Filed:
Jul 6, 2012
Appl. No.:
13/543560
Inventors:
Maher Albitar - Sugar Land TX, US
Michael J. Keating - Houston TX, US
Taghi Manshouri - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
G01N 31/00
G01N 33/53
US Classification:
435 721, 435 4, 435 71, 4352879, 436501, 436518, 427287, 427337, 427338, 530300, 530350
Abstract:
The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.
Control profile
Maher Planinka Albitar from Valley Center, CA, age ~69 Get Report